Influenza and Pneumonia Billing
Medicare covers both the costs of the vaccine and its administration by recognized providers. There is no coinsurance or co-payment applied to this benefit and a beneficiary does not have to meet his or her deductible to receive it. Assignment must be accepted on all vaccine claims and a physician order is not required.
Influenza and pneumonia vaccinations and administration are covered under Part B, not Part D.
If a physician sees a beneficiary for the sole purpose of administering one of these vaccines, an office visit cannot be billed. However, if the beneficiary receives other services which constitute an office visit, then one can be billed.
If both vaccines are administered on the same day, providers are entitled to receive payment for both administration fees.
The diagnosis code used for these vaccines and administration is Z23 (encounter for immunization).
On this page, view the below information:
- Mass Immunizers
- Centralized Billing
- Roster Billing
- Influenza HCPCS and CPT Codes
- Pneumococcal HCPCS and CPT Codes
Mass immunizers offer influenza vaccines, pneumococcal vaccines, or both, to groups of individuals, such as from the public or members of a retirement community.
Mass immunizers can be a traditional provider, such as a physician, or a non-traditional provider, such as a drug store, public health clinic or senior citizen home. CMS created the mass immunizer specialty for those providers that wouldn't otherwise qualify for Medicare enrollment.
Mass Immunizer Requirements:
- Be properly licensed in the State of operation
- Be enrolled in the Medicare Program
- Accept assignment on both vaccinations and administration
- User roster billing
- Bill a MAC, such as Noridian
- Use this process for influenza and pneumococcal vaccinations and administration only
Centralized billing is an option that allows a mass immunizer to send all its influenza and pneumococcal vaccination claims to a single MAC for payment, regardless of where the vaccination was administered. Medicare pays based on the payment locality where the service was provided. This does not include claims for the Railroad Retirement Board, United Mine Workers, or Indian Health Service. These claims need to go to the appropriate processing entity identified by CMS when notification of enrollment as a Centralized Biller is received by CMS.
Centralized Billing Requirements:
- Operate in at least three payment localities where there are three different MACs responsible for processing their claims
- Be enrolled in Medicare as a Mass Immunizer or other provider
- Accept assignment on both the vaccinations and their administration
- Request to participate in the program on an annual basis
- Use roster bills
- Submit claims electronically
- Provide beneficiaries with a record of the pneumococcal vaccination
- Provide beneficiaries written notification of the name of the MAC processing the claims
Roster bills can be submitted on paper or electronically. If billing for both influenza and pneumococcal, these do need to be submitted on separate claims. Do not bill for other services on the same claim. Also, do not use the roster bill for a single beneficiary.
Claim Form Instructions
|Item||>Information to Enter|
|1||"X" in Medicare block|
|2 - Patient's Name||Enter "SEE ATTACHED ROSTER"|
|11 - Insured's Policy Group or Federal Employees' Compensation Act (FECA) Number||Enter "NONE"|
|20 - Outside Lab?||"X" in the NO block|
|21 - Diagnosis or Nature of Illness or Injury|| Line A: Enter "Z23" |
Enter "0" for ICD Indicator between dotted lines
|24B - Place of Service (POS)||Enter "60" on Lines 1 and 2|
|24D - Procedures, Services, or Supplies|| Line 1: Appropriate pneumococcal vaccination or influenza virus vaccination code |
Line 2: G0009 for pneumococcal vaccination administration or G0008 for influenza vaccination administration
|24E - Diagnosis Pointer (Code)|| Line 1: A |
Line 2: A
|24F - Charges|| List charge for each service |
*Not total for all patients
If no charge, enter "0.00"
|27 - Accept Assignment?||Enter "X" in YES block|
|29 - Amount Paid||Enter "$0.00"|
|31 - Signature of Physician or Supplier||Entity's representation must sign|
|32 - Service Facility Location Information||Name, address, and ZIP code|
|32a||National Provider Identifier (NPI) of service facility|
|33 - Billing Provider Info & Phone Number||Enter billing provider information and phone number|
|33a||NPI of billing provider or group|
After the claim is completed, attach a beneficiary roster form with the following information:
- Provider's name and NPI
- Date of service
- MAC's control number
- Medicare number
- Date of birth
- Gender; and
- Signature or stamped "signature on file"
If the beneficiary's actual signature cannot be obtained, the phrase "signature on file" can be used if the provider has a signed authorization on file from the beneficiary to bill Medicare for the services.
Noridian offers rosters on the Forms section of our website. CMS indicates that the pneumococcal roster needs to include the following language:
WARNING: Beneficiaries must be asked if they have received a pneumococcal vaccination.
- Rely on patients' memory to determine prior vaccination status.
CMS allows 95% of the Average Wholesale Price except when furnished in a hospital outpatient department, Rural Health Clinic (RHC) or Federally Qualified Health Center (FQHC), in which those are based on reasonable cost.
To see the allowances, go to the CMS Seasonal Influenza Vaccines Pricing webpage.
Influenza HCPCS and CPT Codes
|G0008||Administration of influenza virus vaccine|
|90630||Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, for intradermal use|
|90653||Influenza virus vaccine, inactivated, subunit, adjuvanted, for intramuscular use|
|90654||Influenza virus vaccine, split virus, preservative-free, for intradermal use, for adults ages 18 – 64;|
|90655||Influenza virus vaccine, split virus, preservative free, for children 6- 35 months of age, for intramuscular use;|
|90656||Influenza virus vaccine, split virus, preservative free, for use in individuals 3 years and above, for intramuscular use;|
|90657||Influenza virus vaccine, split virus, for children 6-35 months of age, for intramuscular use;|
|90660||Influenza virus vaccine, live, for intranasal use;|
|90661||Influenza virus vaccine, derived from cell cultures, subunit, preservative and antibiotic free, for intramuscular use|
|90662||Influenza virus vaccine, split virus, preservative free, enhanced immunogenicity via increased antigen content, for intramuscular use|
|90672||Influenza virus vaccine, live, quadrivalent, for intranasal use|
|90673||Influenza virus vaccine, trivalent, derived from recombinant DNA (RIV3), hemagglutinin (HA) protein only, preservative and antibiotic free, for intramuscular use|
|90674||Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, preservative and antibiotic free, 0.5 mL dosage, for intramuscular use|
|90682||Influenza virus vaccine, quadrivalent (RIV4), derived from recombinant DNA, hemagglutinin (HA) protein only, preservative and antibiotic free, for intramuscular use|
|90685||Influenza virus vaccine, quadrivalent, split virus, preservative free, when administered to children 6-35 months of age, for intramuscular use|
|90686||Influenza virus vaccine, quadrivalent, split virus, preservative free, when administered to individuals 3 years of age and older, for intramuscular use|
|90687||Influenza virus vaccine, quadrivalent, split virus, when administered to children 6-35 months of age, for intramuscular use|
|90688||Influenza virus vaccine, quadrivalent, split virus, when administered to individuals 3 years of age and older, for intramuscular use|
|90756||Influenza virus vaccine, quadrivalent, derived from cell cultures, subunit, antibiotic free, 0.5mL dosage, for intramuscular use) Effective 1/1/2018|
|Q2035||Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (Afluria)|
|Q2036||Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (Flulaval)|
|Q2037||Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (Fluvirin)|
|Q2038||Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (Fluzone)|
|Q2039||Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (not otherwise specified)|
Pneumococcal HCPCS and CPT Codes
|G0009||Administration of pneumococcal vaccine|
|90669||Pneumococcal conjugate vaccine, polyvalent, for children under 5 years, for intramuscular use|
|90670||Pneumococcal conjugate vaccine, 13 valent, for intramuscular use|
|90732||Pneumococcal polysaccharide vaccine, 23-valent, adult or immunosuppressed patient dosage, for use in individuals 2 years or older, for subcutaneous or intramuscular use;|
- CMS Change Request (CR)8098 - Vaccines Furnished at Hospice
- CMS Internet Only Manual (IOM), Publication 100-02, Medicare Benefit Policy Manual, Chapter 15 - Immunizations
- CMS Medicare Learning Network (MLN) Matters Special Edition (SE)17026: 2017 - 2018 Influenza (Flu) Resources for Health Care Professionals
Last Updated Nov 29, 2018